Intuitive Surgical, Inc. logo ISRG - Intuitive Surgical, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 39
HOLD 12
SELL 5
STRONG
SELL
0
| PRICE TARGET: $525.00 DETAILS
HIGH: $750.00
LOW: $400.00
MEDIAN: $505.00
CONSENSUS: $525.00
UPSIDE: 49.97%

Stock News

Intuitive Surgical: The Correction Has Done The Work The Fundamentals Could Not

Intuitive Surgical: The Correction Has Done The Work The Fundamentals Could Not

Intuitive Surgical, Inc. has declined ~38% since my previous Hold, driven by valuation concerns and recent structural headwinds. Despite ISRG's Q2 2026 earnings growth, margin expansion, and raised guidance, markets reacted to a slowdown in U.S. procedure growth. Pressures stem from expiring ACA subsidies impacting elective surgeries and weight loss drugs reducing bariatric procedure demand.

Jul 20, 2026 04:46 AM seekingalpha.com
Intuitive Surgical Q2: The Market Is Missing The Bigger Picture

Intuitive Surgical Q2: The Market Is Missing The Bigger Picture

Intuitive Surgical, Inc. remains a compelling long-term compounder, with operational improvements and robust growth prospects despite recent market headwinds. ISRG delivered solid Q2 results: revenue and EPS beat estimates, da Vinci procedures grew 20%, and gross margin reached 70%, reinforcing ISRG's strong positioning. Current valuation near a 5-year low—~35x forward earnings—offers a more attractive entry point, with multiple compression creating a margin of safety.

Jul 17, 2026 03:31 PM seekingalpha.com
Intuitive Surgical shares fall as procedure growth slows despite Q2 earnings beat

Intuitive Surgical shares fall as procedure growth slows despite Q2 earnings beat

Intuitive Surgical (NASDAQ: ISRG) shares fell about 11% on Friday after the robotic surgery company reported second-quarter results that topped Wall Street expectations but disappointed investors with slower US procedure growth and a cautious full-year outlook. The company reported second quarter revenue of $2.89 billion, up 19% from a year earlier and above analysts' consensus estimate of $2.82 billion.

Jul 17, 2026 06:44 AM proactiveinvestors.com

Price Targets